Shen et al. demonstrated that the interplay between GAL1 and bladder cancer invasiveness and that between GAL1 and progression was mediated via the Ras-Rac1-MEKK4-JNK-AP1 signaling pathway [26]. Here, MAP3K4 is linked to urinary bladder carcinoma.